NasdaqGS - Nasdaq Real Time Price
USD
Regeneron Pharmaceuticals, Inc. (REGN)
907.61
+88.83
(+10.85%)
As of 1:43:52 PM EDT. Market Open.
Trade REGN on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
B of A Securities
66/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/28/2026
Analyst
Canaccord Genuity
Rating Action
Maintains
Rating
Buy
Price Action
Raises
Price Target
875 -> 922
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
B of A Securities
|
66 | 63 | 99 | Buy
|
860 | 2026-01-08 |
|
Argus Research
|
64 | 71 | 64 | Buy
|
850 | 2026-10-02 |
|
Jefferies
|
59 | 53 | 99 | Buy
|
930 | 2026-10-01 |
|
Truist Securities
|
58 | 54 | 100 | Buy
|
780 | 2026-10-07 |
|
Guggenheim
|
58 | 61 | 74 | Buy
|
1030 | 2026-08-03 |
|
Canaccord Genuity
|
53 | 51 | 77 | Buy
|
922 | 2026-10-29 |
|
TD Cowen
|
53 | 52 | 99 | Buy
|
980 | 2026-10-21 |
|
Oppenheimer
|
53 | 51 | 88 | Outperform
|
865 | 2026-02-02 |
|
Leerink Partners
|
53 | 38 | 99 | Market Perform
|
824 | 2026-08-18 |
|
Bernstein
|
52 | 53 | 76 | Outperform
|
921 | 2026-04-09 |
Rows per page
1-10 of 22
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 10/28/2026 |
| Maintains | TD Cowen: Buy to Buy | 10/21/2026 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/19/2026 |
| Upgrade | UBS: Neutral to Buy | 10/15/2026 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 10/8/2026 |
| Maintains | Truist Securities: Buy to Buy | 10/7/2026 |
